Consumer Research
Legal Cannabis Sales Are on Track to Rebound in 2026, Whitney Economics Forecasts
NEW YORK – After a year that delivered the first ...
Single DMT Dose Shows Promise in Cutting TRD Symptoms
NEW YORK – A single intravenous dose of the psychedelic ...
Massachusetts Tops $9 Billion in Cannabis Sales, Eyes Cultivation License Freeze
BOSTON – Massachusetts adult-use Cannabis retailers have surpassed $9 billion ...
Cannabis Market’s Hidden Scale: New Estimates Point to $90B U.S. Potential
LOS ANGELES – Viridian Capital Advisors' latest Chart of the Week dives into recreational Cannabis sales across nine mature markets (Michigan, Montana, Alaska, New Mexico, Massachusetts, Colorado, Oregon, Washington, and Nevada) to gauge true consumer ...
Republican State AGs Challenge Trump’s Cannabis Rescheduling Directive
LOS ANGELES – A coalition of Republican attorneys general from eight states has publicly rejected President Donald Trump's recent Executive Order to reschedule Cannabis under the Controlled Substances Act, citing persistent risks to public safety ...
Banks Still Hesitant on Expanding Services for Cannabis Businesses Post-Trump Rescheduling Order
LOS ANGELES – President Donald Trump's Executive Order fast-tracked the move to reschedule Cannabis under the Controlled Substances Act, aiming to ease research barriers and tax deductions for state-legal operators. Yet even as this policy ...
Trulieve Redeems $368M in Notes, Signaling Debt Reduction Push
TALLAHASSEE – Trulieve Cannabis Corp. has announced its decision to redeem its entire $368 million portfolio of 8.0% senior secured notes, due in 2026. The company issued the redemption notice, setting an early payoff date ...
Jushi Holdings Reports Q3 2025 Financial Results
LOS ANGELES – Jushi Holdings Inc., a vertically integrated Cannabis operator with footprints in six states, disclosed third-quarter 2025 financials that showed revenue climbing 6.6% year-over-year to $65.7 million, driven by higher wholesales and customer ...
Compass Pathways Advances Psilocybin Therapy Timeline for Depression Treatment
LONDON & NEW YORK – Compass Pathways reported Q3 2025 financial results and signaled a faster path to market for its lead psilocybin-based therapy in treatment-resistant depression (TRD). The biotechnology firm now targets commercialization readiness ...
Missouri Trade Group Report Finds 96% of Tested Hemp Products Exceed THC Thresholds
KANSAS CITY – A new investigation by the Missouri Cannabis Trade Association (MoCannTrade) has concluded that nearly all hemp-derived products sold at unregulated retailers in the state contain illegal levels of THC, raising questions about ...
Trump’s Rescheduling Order Ignites State Cannabis Momentum in Pennsylvania, Tennessee, and Wyoming
LOS ANGELES – President Donald Trump's directive last week to fast-track Cannabis's rescheduling has handed lawmakers in several conservative-leaning states a timely political opening to advance Cannabis reforms. The executive order, signed on December 18, ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors wrapped up 2025 on a high note, with federal policy breakthroughs and corporate maneuvers signaling sustained growth potential across Cannabis & Psychedelics. Over the past two weeks, President Trump's ...
Texas Awards $50M Grant to Spearhead Ibogaine Trials
AUSTIN – The Texas Health and Human Services Commission has granted $50 million to a statewide consortium led by UTHealth Houston and the University of Texas Medical Branch at Galveston, marking the formal launch of ...
Maryland Supreme Court Refuses to Review Injunction on Anti-Intoxicating Hemp Law
LOS ANGELES- The Maryland Supreme Court has recently opted not to review a lower court's injunction against the enforcement of the state's law aimed at banning intoxicating hemp products. This decision, as detailed in a ...
Georgia Advances Medical Cannabis Program After Legal Delays
LOS ANGELES' In a significant development for Georgia's medical cannabis sector, state regulators have resumed the licensing process, concluding a prolonged two-year legal standoff. This move, as reported by the Valdosta Daily Times, comes after ...
Algernon Pharmaceuticals Partners with Seyltx Inc.
LOS ANGELES- Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, has announced a significant advancement in its research program. The company has signed a Letter of Intent (LOI) with Seyltx Inc., a U.S.-based ...
Psychedelic Therapy for PTSD: Veterans Seek Healing in Mexico Amid U.S. Legal Restrictions
LOS ANGELES- A recent CBS News report has brought to light a significant trend among veterans dealing with PTSD: an increasing number are seeking psychedelic-assisted treatments in Mexico, utilizing substances currently deemed illegal by the ...
Optimi Health Obtains Key Amendment to Dealer’s Licence
LOS ANGELES- Optimi Health, a Canadian company specializing in psychedelic drug research and formulation, has achieved a significant milestone with Health Canada's approval of an amendment to its Dealer's Licence. This crucial development allows Optimi ...
Germany Amends Cannabis Legalization Bill, Balancing Reform and Regulation
BERLIN- German lawmakers have significantly revised the country's cannabis legalization bill, incorporating feedback from cannabis reform advocates and aiming for the bill's enactment in the upcoming spring. This development, as reported by Marijuana Moment, ...
Psyence Group Inc. Announces Resignation of Board Member Marvin Singer
LOS ANGELES- Psyence Group Inc a clinical-stage life science biotechnology firm at the forefront of utilizing nature-derived psilocybin for mental health and wellbeing, today announced the resignation of Mr. Marvin Singer from his role as ...
Compass Pathways Launches UK Phase of Landmark Psilocybin Study for Treatment-Resistant Depression
NEW YORK- Compass Pathways plc (Nasdaq: CMPS), a biotechnology leader dedicated to advancing mental health treatments, has announced the initiation of the UK component of its phase 3 program investigating COMP360 psilocybin treatment for treatment-resistant ...
Alabama Medical Cannabis Commission Settles Lawsuits
LOS ANGELES- The Alabama Medical Cannabis Commission (AMCC) has made significant strides this week by reaching a settlement with license applicants, a move aimed at resolving the multiple lawsuits filed against the agency. This development, ...
Swedish Researchers Use Psychedelics to Explore Brain Function and AI Development
LOS ANGELES- In a groundbreaking study at Lund University in Sweden, researchers are employing psychedelic substances, specifically acid (LSD) and ketamine, to delve into the intricate workings of the brain. This unique approach aims to ...
Minnesota Tests New Saliva-Based Roadside Cannabis Impairment Assessment
LOS ANGELES- In a groundbreaking move, Minnesota's Office of Traffic Safety (OTS) has initiated a pilot program to test a saliva-based roadside cannabis impairment test. This innovative approach is designed to enhance the state's capabilities ...
New York and Missouri’s Contrasting Cannabis Market Progress in 2023
NEW YORK- In a striking contrast of cannabis market development, New York and Missouri have reported significantly differing sales figures in 2023. New York's licensed cannabis dispensaries have achieved over $100 million in adult-use sales, ...
Cybin Inc. Secures $30 Million in Funding to Advance Psychedelic Treatment Research
NEW YORK- Toronto-based Cybin Inc., a clinical-stage biopharmaceutical company, has successfully completed a significant funding round, bolstering its commitment to revolutionize mental healthcare through the development of innovative psychedelic treatments. The company announced the closure ...
Clearmind Medicine Inc. Announces Reverse Share Split to Comply with Nasdaq Regulations
NEW YORK- Clearmind Medicine Inc., a biotech company renowned for its innovative work in developing psychedelic-derived therapeutics, has announced a strategic decision to conduct a reverse share split of its ordinary shares. This move is ...
Revive Therapeutics Advances Development of Innovative Bucillamine Formulation for Medical Emergencies
LOS ANGELES- Revive Therapeutics Ltd, a specialty life sciences company, has recently announced significant progress in the development of a new lyophilized formulation of Bucillamine, a drug initially designed for medical needs and rare disorders. ...
Oklahoma Prolongs Medical Cannabis License Moratorium to 2026 Amid Regulatory Review
LOS ANGELES- In a significant move for the state's cannabis industry, Oklahoma has decided to extend its moratorium on new medical cannabis licenses up to 2026, as reported by Tulsa World. This extension hinges on ...
New York Sets Stringent Regulations on Hemp Products, Banning Delta-8 and Other THC Variants
NEW YORK- New York's cannabis regulatory framework has reached a new milestone with the finalization of rules governing intoxicating hemp products. The state's regulators have imposed a ban on specific THC variants, including Delta-8 THC, ...
Pennsylvania Moves to Expand Medical Cannabis Retail Access, Breaking Up Potential Monopoly
NEW YORK- Pennsylvania is poised to significantly expand its medical cannabis industry, with new legislation on the horizon that could allow all of its 25 medical cannabis grower/processor licensees to also operate retail outlets. This ...
California Regulators Impose Embargo on Cannabis Products from Three Companies Over Safety Concerns
LOS ANGELES- California's Department of Cannabis Control (DCC) has taken decisive action by imposing an embargo on cannabis products from three companies, citing concerns that these products may have been "adulterated" and potentially harmful. This ...
South Dakota on the Cusp of Major Cannabis Reform with New Adult-Use Ballot Initiatives
LOS ANGELES- In a significant development for cannabis legislation, South Dakota has introduced two new adult-use cannabis legalization measures, aiming for inclusion in the 2024 general election. Both initiatives require 17,509 valid signatures from registered ...
Navigating the Green: Unraveling the Taxing Dilemma in the Cannabis Industry
LOS ANGELES- In the ever-expanding landscape of the cannabis industry, where green is not just a color but a thriving economic force, the question of taxation looms large. As states grapple with the complex task ...
Silo Pharma Secures Exclusive License for MedSpray’s Intranasal Technology for SPC-15 Drug Delivery
NERW YORK – Silo Pharma, Inc. a biopharmaceutical company at the forefront of merging traditional therapeutics with psychedelic research, announced today its new exclusive licensing agreement with Medspray Pharma BV. This agreement centers around Medspray's ...
New York Finalizes Regulations for Intoxicating Hemp Products, Banning Certain THC Variants
NEW YORK – New York's cannabis regulators have recently established definitive rules for intoxicating hemp products, introducing a series of restrictions and standards that are expected to reshape the hemp market in the state. As ...
Hawaii Attorney General Proposes Comprehensive Plan for Recreational Cannabis Legalization
LOS ANGELES– Hawaii Attorney General Anne Lopez recently unveiled a detailed proposal to legalize recreational cannabis, marking a significant step forward in the state's cannabis policy reform. This initiative comes eight months after a similar ...
Ohio Senate President Seeks Changes to Cannabis Legalization Law Amid Controversy
LOS ANGELES- In a move that is stirring debate, Ohio State Senate President Matt Huffman is spearheading a bipartisan effort to revise Ohio's recently approved cannabis legalization law, Issue 2, before its main provisions take ...
